Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis

Endocrinology

Volumn 153, Issue 4, 2012, Pages 1774-1782

  Oki, Kenji ^a,b   Plonczynski, Maria W ^a,b   Lam, Milay Luis ^a,b   Gomez Sanchez, Elise P ^a,b   Gomez Sanchez, Celso E ^a,b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; CALCIUM; CALMODULIN; FORSKOLIN; INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL J5; NIFEDIPINE; POTASSIUM; UNCLASSIFIED DRUG;

ADRENAL CORTEX CARCINOMA; ALDOSTERONE RELEASE; ARTICLE; CALCIUM TRANSPORT; CANCER CELL CULTURE; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; LENTIVIRINAE; PRIORITY JOURNAL; SODIUM TRANSPORT;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ALDOSTERONE; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALMODULIN; CELL LINE, TUMOR; CELL PROLIFERATION; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MUTATION; NIFEDIPINE; SODIUM; SULFONAMIDES;

EID: 84859410866     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1733     Document Type: Article

References (47)

1. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young Jr WF, Montori VM 2008 Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:3266-3281
2. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ 2005 Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45:1243-1248 (Pubitemid 40523144)
3. Mulatero P, Bertello C, Rossato D, Mengozzi G, Milan A, Garrone C, Giraudo G, Passarino G, Garabello D, Verhovez A, Rabbia F, Veglio F 2008 Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J Clin Endocrinol Metab 93:1366-1371 (Pubitemid 351519734)
4. Lifton RP, Dluhy RG, Powers M, Rich GM, Gutkin M, Fallo F, Gill Jr JR, Feld L, Ganguly A, Laidlaw JC, Murnaghan DJ, Kauffman C, Stockigt J, Ulick l, Lalouel J-M 1992 Hereditary hypertension caused by chimeric gene duplication and ectopic expression of aldosterone synthase. Nat Genet 2:66-74
5. Pascoe L, Curnow KM, Slutsker L, Connell JM, Speiser PW, New MI, White PC 1992 Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. Proc Natl Acad Sci USA 89:8327-8331
6. Gomez-Sanchez CE, Gill Jr JR, Ganguly A, Gordon RD 1988 Glucocorticoid-suppressible aldosteronism: a disorder of the adrenal transitional zone. J Clin Endocrinol Metab 67:444-448
7. Sukor N, Mulatero P, Gordon RD, So A, Duffy D, Bertello C, Kelemen L, Jeske Y, Veglio F, Stowasser M 2008 Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families. J Hypertens 26:1577-1582
8. Geller DS, Zhang J, Wisgerhof MV, Shackleton C, Kashgarian M, Lifton RP 2008 A novel form of human mendelian hypertension featuring nonglucocorticoid- remediable aldosteronism. J Clin Endocrinol Metab 93:3117-3123
9. Spät A, Hunyady L 2004 Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev 84:489-539 (Pubitemid 38365491)
10. Choi M, Scholl UI, Yue P, Björklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men CJ, Lolis E, Wisgerhof MV, Geller DS, Mane S, Hellman P, Westin G, Åkerström G, Wang W, Carling T, Lifton RP 2011 K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331:768-772
11. Heginbotham L, Abramson T, MacKinnon R 1992 A functional connection between the pores of distantly related ion channels as revealed by mutant K+ channels. Science 258:1152-1155
12. Dibb KM, Rose T, Makary SY, Claydon TW, Enkvetchakul D, Leach R, Nichols CG, Boyett MR 2003 Molecular basis of ion selectivity, block, and rectification of the inward rectifier Kir3.1/Kir3.4 K(+) channel. J Biol Chem 278:49537-49548
13. 2+/calmodulin-dependent protein kinase II. J Clin Invest 116:2403-2412
14. Condon JC, Pezzi V, Drummond BM, Yin S, Rainey WE 2002 Calmodulin-dependent kinase I regulates adrenal cell expression of aldosterone synthase. Endocrinology 143:3651-3657 (Pubitemid 34925742)
15. Parmar J, Key RE, Rainey WE 2008 Development of an adrenocorticotropin- responsive human adrenocortical carcinoma cell line. J Clin Endocrinol Metab 93:4542-4546 (Pubitemid 352789558)
16. Wang T, Rainey WE 5 September 2011 Human adrenocortical carcinoma cell lines. Mol Cell Endocrinol 10.1016/j.mce.2011.08.041
17. Yang X, Boehm JS, Yang X, Salehi-Ashtiani K, Hao T, Shen Y, Lubonja R, Thomas SR, Alkan O, Bhimdi T, Green TM, Johannessen CM, Silver SJ, Nguyen C, Murray RR, Hieronymus H, Balcha D, Fan C, Lin C, Ghamsari L, Vidal M, Hahn WC, Hill DE, Root DE 2011 A public genome-scale lentiviral expression library of human ORFs. Nat Methods 8:659-661
18. Mitta B, Rimann M, Ehrengruber MU, Ehrbar M, Djonov V, Kelm J, Fussenegger M 2002 Advanced modular self-inactivating lentiviral expression vectors for multigene interventions in mammalian cells and in vivo transduction. Nucleic Acids Res 30:e113
19. Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS, Sabatini DM, Chen IS, Hahn WC, Sharp PA, Weinberg RA, Novina CD 2003 Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9:493-501 (Pubitemid 36356735)
20. Thomas M, Lu JJ, Ge Q, Zhang C, Chen J, Klibanov AM 2005 Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. Proc Natl Acad Sci USA 102:5679-5684 (Pubitemid 40559619)
21. Romero DG, Gomez-Sanchez EP, Gomez-Sanchez CE 2010 Angiotensin II-regulated transcription regulatory genes in adrenal steroidogenesis. Physiol Genomics 42A:259-266
22. Romero DG, Plonczynski MW, Welsh BL, Gomez-Sanchez CE, Zhou MY, Gomez-Sanchez EP 2007 Gene expression profile in rat adrenal zona glomerulosa cells stimulated with aldosterone secretagogues. Physiol Genomics 32:117-127
23. Romero DG, Zhou MY, Yanes LL, Plonczynski MW, Washington TR, Gomez-Sanchez CE, Gomez-Sanchez EP 2007 Regulators of G-protein signaling 4 in adrenal gland: localization, regulation, and role in aldosterone secretion. J Endocrinol 194:429-440 (Pubitemid 47249679)
24. Tannous BA 2009 Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo. Nat Protoc 4:582-591
25. Berridge MV, Herst PM, Tan AS 2005 Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev 11:127-152 (Pubitemid 41510276)
26. Gomez-Sanchez CE, Foecking MF, Ferris MW, Chavarri MR, Uribe L, Gomez-Sanchez EP 1987 The production of monoclonal antibodies against aldosterone. Steroids 49:581-587
27. Morra di Cella S, Veglio F, Mulatero P, Christensen V, Aycock K, Zhu Z, Gomez-Sanchez EP, Gomez-Sanchez CE 2002 A time-resolved fluoroimmunoassay for 18-oxocortisol and 18-hydroxycortisol. Development of a monoclonal antibody to 18-oxocortisol. J Steroid Biochem Mol Biol 82:83-88
28. Mikhaylova IV, Kuulasmaa T, Jääskeläinen J, Voutilainen R 2007 Tumor necrosis factor-α regulates steroidogenesis, apoptosis, and cell viability in the human adrenocortical cell line NCI-H295R. Endocrinology 148:386-392 (Pubitemid 46021471)
29. Planas-Silva MD, Means AR 1992 Expression of a constitutive form of calcium/calmodulin dependent protein kinase II leads to arrest of the cell cycle in G2. EMBO J 11:507-517
30. 2+-signal-dependent growth regulation by radicicol in budding yeast. Biosci Biotechnol Biochem 72:132-138
31. + channel Kir2.2 at 3.1 A resolution. Science 326:1668-1674
32. Heitzmann D, Derand R, Jungbauer S, Bandulik S, Sterner C, Schweda F, El Wakil A, Lalli E, Guy N, Mengual R, Reichold M, Tegtmeier I, Bendahhou S, Gomez-Sanchez CE, Aller MI, Wisden W, Weber A, Lesage F, Warth R, Barhanin J 2008 Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis. EMBO J 27:179-187
33. Davies LA, Hu C, Guagliardo NA, Sen N, Chen X, Talley EM, Carey RM, Bayliss DA, Barrett PQ 2008 TASK channel deletion in mice causes primary hyperaldosteronism. Proc Natl Acad Sci USA 105:2203-2208 (Pubitemid 351439489)
34. Nelson MT, Cheng H, Rubart M, Santana LF, Bonev AD, Knot HJ, Lederer WJ 1995 Relaxation of arterial smooth muscle by calcium sparks. Science 270:633-637
35. Grimm PR, Irsik DL, Settles DC, Holtzclaw JD, Sansom SC 2009 Hypertension of Kcnmb1-/- is linked to deficient K secretion and aldosteronism. Proc Natl Acad Sci USA 106:11800-11805
36. Coyne MD, Cornelius P, Venditti N, Toscano DG, Gross MK, Toscano Jr WA 1985 Purification and properties of calmodulin from adrenal cortex. Arch Biochem Biophys 236:629-637 (Pubitemid 15137869)
37. Antonini SR, Baldacchino V, Tremblay J, Hamet P, Lacroix A 2006 Expression of ACTH receptor pathway genes in glucose-dependent insulinotrophic peptide (GIP)-dependent Cushing's syndrome. Clin Endocrinol (Oxf) 64:29-36
38. Wisgerhof M, Brown RD, Hogan MJ, Carpenter PC, Edis AJ 1981 The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism. J Clin Endocrinol Metab 52:195-198 (Pubitemid 11183610)
39. Kem DC, Weinberger MH, Higgins JR, Kramer NJ, Gomez-Sanchez C, Holland OB 1978 Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension. J Clin Endocrinol Metab 46:552-560
40. Seccia TM, Miotto D, De Toni R, Pitter G, Mantero F, Pessina AC, Rossi GP 2009 Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols. Hypertension 53:761-766
41. Sackmann S, Lichtenauer U, Shapiro I, Reincke M, Beuschlein F 2011 Aldosterone producing adrenal adenomas are characterized by activation of calcium/calmodulin-dependent protein kinase (CaMK) dependent pathways. Horm Metab Res 43:106-111
42. Lenzini L, Seccia TM, Aldighieri E, Belloni AS, Bernante P, Giuliani L, Nussdorfer GG, Pessina AC, Rossi GP 2007 Heterogeneity of aldosterone-producing adenomas revealed by a whole transcriptome analysis. Hypertension 50:1106-1113 (Pubitemid 350172933)
43. Hamlet SM, Gordon RD, Gomez-Sanchez CE, Tunny TJ, Klemm SA 1988 Adrenal transitional zone steroids, 18-oxo and 18-hydroxycortisol, useful in the diagnosis of primary aldosteronism are ACTH-dependent. Clin Exp Pharmacol Physiol 15:317-322
44. Yamakita N, Mune T, Morita H, Yoshida H, Yasuda K, Miura K, Gomez-Sanchez CE 1994 Plasma 18-oxocortisol levels in the patients with adrenocortical disorders. Clin Endocrinol (Oxf) 40:583-587 (Pubitemid 24194660)
45. Rey O, Young SH, Jacamo R, Moyer MP, Rozengurt E 2010 Extracellular calcium sensing receptor stimulation in human colonic epithelial cells induces intracellular calcium oscillations and proliferation inhibition. J Cell Physiol 225:73-83
46. Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Sandler RS, Rothstein R, Summers RW, Snover DC, Beck GJ, Bond JH, Greenberg ER 1999 Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 340:101-107 (Pubitemid 29054844)
47. Roderick HL, Cook SJ 2008 Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival. Nat Rev Cancer 8:361-375 (Pubitemid 351589702)